Dyslipidemia Program PDF Print E-mail

The Canadian Cardiovascular Society Dyslipidemia Guidelines help Canadian physicians to diagnose and treat dyslipidemia (high lipid count) in patients and thereby help prevent cardiovascular disease. Below you will find a link to the CCS guidelines as well as our dyslipidemia guideline knowledge translation tools and resources; including smart phone apps, educational slide decks, pocket guides and more.  Watch this page for announcements about educational webinars, workshops and accredited e-learning programs.

The 2012 Dyslipidemia Guideline Update is now published in the Canadian Journal of Cardiology . Many developments have occurred since the publication of the widely-used CCS Dyslipidemia guidelines. The 2012 update presents an updated version of the guidelines, incorporating new recommendations based on recent findings and harmonizing CCS guidelines with those from other Societies. Link to guidelines

apgcapture   Dyslipidemia Guidelines



Dyslipidemia Guidelines App

The Updated CCS Dyslipidemia Guidelines app is now available on iTunes and Google play – download yours today!

The CCS Lipid Guidelines App is based on the 2012 Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. This App facilitates the adoption of the CCS Lipid guidelines into daily clinical practice by healthcare professionals.

The updated 2012 CCS Dylipidemia Guidelines app has many new and exciting features to offer including an updated Framingham Risk Score (FRS) and cadiovascular (CV) age calculator, a new non-HDL-C calculator, a new video section, new flow chart management algorithms, a new landmark lipid trials section, a new drug information section, and an updated guideline library.


icon512 app_store_badge_en_0609

Visit the CCS App page to view more CCS Apps


Slide Decks

2012 CCS Dyslipidemia Guidelines Update English PPT

2012 CCS Dyslipidemia Guidelines Update French PPT

2012 Statin Intolerance and Adverse Effects: Canadian Working Group Consensus   PPT | PDF

2009 CCS Dyslipidemia Guidelines  (English)   PPT PDF

2009 CCS Dyslipidemia Guidelines  (French)   PPTPDF


Pocket Guides

2012 CCS Dyslipidemia Guidelines Update (English Version 

2012 CCS Dyslipidemia Guidelines Update (French Version)    



CCC 2013 Guideline Workshops (Recordings)

Due to file size and connection speed, videos may take some time to load. Please note, these workshop recordings were recorded live during CCC at Vascular 2013.

Dyslipidemia  (English Recording)

Dyslipidemia (French Recording)

Viewing these videos has been determined by the Royal College to meet the criteria for a Self-Learning: Scanning Activity and is eligible for Section 2 credits under the Maintenance of Certification (MOC) Program. Remember to visit MAINPORT to record your learning and outcomes.


Section 1 Accredited E-Learning Programs

Challenges of Lowering LDL-C: The Role of PCSK-9
Section 1 credits: 1
Expiry Date: April 16, 2014



Canadian Cardiovascular Society Guidelines 2012 Update: Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult (Webinar Slides with Audio)

Please note: You will be prompted to enter your email address and then your first and last name to download/stream the file.

Canadian Cardiovascular Society Guidelines 2012 Update: Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult - Slide Deck



CCS is pleased to provide three highly engaging videos based on the 2009 Dyslipidemia Guidelines.

These videos address existing educational needs of health care professionals including primary care physicians, nurses and pharmacists as identified by a recent CCS needs assessment. Each video is 8-10 minutes and is designed to improve understanding of the 2009 Dyslipidemia Guidelines and put them into practice. Following each video, viewers will have an opportunity to test their knowledge and evaluate the video content.

Start watching now as a team of multidisciplinary cardiovascular health experts present on the following important topics.

Module 1 - Screening for CVD: The Importance of Family History

Module 2 - Risk Stratification and Treatment Target Selection

Module 3 - Strategies to Achieve Treatment Targets


view videos



It is Canadian Cardiovascular Society policy that no industry support is accepted for the development of guidelines or position statements.

The CCS accepts third party funding for guideline knowledge translation activities, seeking multiple supporters whenever possible. Support is accepted to offset the development and delivery costs of tools, resources, workshops and webinars.   Supporters have no involvement in content development. Dyslipidemia Guideline knowledge translation is currently supported by: Merck, Amgen and Pfizer.

Merke_logo     Amgen   



Last Updated on Sunday, 16 February 2014